Literature DB >> 30341715

Occurrence of hepatocellular carcinoma 24 years after successful interferon therapy in a patient with chronic hepatitis C: a case report.

Yuichi Yoshida1, Miki Yonezawa2, Takuya Okamoto2, Yudai Fujiwara2, Akiko Suzuki2, Yuji Suzuki2, Kei Endo2, Keisuke Kakisaka2, Takayoshi Oikawa2, Hidekatsu Kuroda2, Akio Miyasaka2, Yasuhiro Takikawa2.   

Abstract

An 82-year-old man presented with hepatocellular carcinomas (HCCs) 24 years after achieving a sustained virological response (SVR) to an interferon for hepatitis C. His hepatic fibrosis stage was F1 when he was treated at 58 years. He was followed-up by annual blood tests and abdominal ultrasonography or computed tomography. After the IFN treatment, he had drunk approximately 100 g of ethanol. Serum aspartate aminotransferase and gamma-glutamyl transpeptidase levels had been elevated since 2012. To investigate the possible factors that affect hepatocarcinogenesis over 10 years after achieving an SVR, we reviewed the literature. Of 39 reported patients, 26, as well as ours, had one or more lifestyle-related factors, including body mass index ≥ 25 kg/m2, diabetes mellitus, impaired glucose tolerance, hepatosteatosis, or alcohol consumption. In our patient, aging and daily alcohol consumption might have triggered the development of HCCs.

Entities:  

Keywords:  Alcohol consumption; Body mass index; Diabetes mellitus; Hepatosteatosis; Sustained virological response

Mesh:

Substances:

Year:  2018        PMID: 30341715     DOI: 10.1007/s12328-018-0915-8

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  23 in total

1.  Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.

Authors:  Akiko Makiyama; Yoshito Itoh; Akinori Kasahara; Yasuharu Imai; Sumio Kawata; Kentaro Yoshioka; Hirohito Tsubouchi; Kendo Kiyosawa; Shinichi Kakumu; Kiwamu Okita; Norio Hayashi; Takeshi Okanoue
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

2.  Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy.

Authors:  Yukiko Ito; Natsuyo Yamamoto; Ryo Nakata; Yoshihisa Kato; Masashi Iori; Keisuke Sakai; Tamiko Takemura; Ryosuke Tateishi; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

3.  Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers.

Authors:  J B Whitfield; G Zhu; A C Heath; L W Powell; N G Martin
Journal:  Alcohol Clin Exp Res       Date:  2001-07       Impact factor: 3.455

4.  Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy.

Authors:  Yoshiaki Iwasaki; Kouichi Takaguchi; Hiroshi Ikeda; Yasuhiro Makino; Yasuyuki Araki; Masaharu Ando; Haruhiko Kobashi; Toshitsugu Kobatake; Ryoji Tanaka; Minoru Tomita; Tomonori Senoh; Mitsuhiko Kawaguchi; Toshinari Shimoe; Koji Manabe; Keiji Kita; Junnosuke Shimamura; Kohsaku Sakaguchi; Yasushi Shiratori
Journal:  Liver Int       Date:  2004-12       Impact factor: 5.828

5.  Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

Authors:  Kazuki Ikeda; Hiroyuki Marusawa; Yukio Osaki; Takefumi Nakamura; Naoto Kitajima; Yukitaka Yamashita; Masatoshi Kudo; Tosiya Sato; Tsutomu Chiba
Journal:  Ann Intern Med       Date:  2007-05-01       Impact factor: 25.391

6.  Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C.

Authors:  Kensaku Sanefuji; Hiroto Kayashima; Tomohiro Iguchi; Keishi Sugimachi; Yo-Ichi Yamashita; Tomoharu Yoshizumi; Yuji Soejima; Takashi Nishizaki; Akinobu Taketomi; Yoshihiko Maehara
Journal:  J Surg Oncol       Date:  2009-01-01       Impact factor: 3.454

7.  [Case of double cancer of the liver, cholangiocarcinoma and hepatocellular carcinoma detected in a patient with hepatitis C 13 years after diminution of HCV-RNA by interferon treatment].

Authors:  Takako Tsumura; Shintaro Takaki; Hiroshi Aikata; Yuki Kimura; Yoshio Katamura; Takahiro Azakami; Tomokazu Kawaoka; Masataka Tsuge; Hiromi Sanetou; Koji Waki; Akira Hiramatsu; Michio Imamura; Yoshiiku Kawakami; Shoichi Takahashi; Koji Arihiro; Kazuaki Chayama
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2009-05

8.  Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection.

Authors:  Takehiro Hayashi; Akihiro Tamori; Manabu Nishikawa; Hiroyasu Morikawa; Masaru Enomoto; Hiroki Sakaguchi; Daiki Habu; Norifumi Kawada; Shoji Kubo; Shuhei Nishiguchi; Susumu Shiomi
Journal:  Liver Int       Date:  2008-05-19       Impact factor: 5.828

9.  [Hepatocellular carcinoma occurring after 11 year-long sustained viral response to interferon therapy for chronic hepatitis C].

Authors:  Fumi Suganami; Yasuyuki Tomiyama; Kenji Ohmoto; Tomoya Kawase; Naoko Yoshioka; Norikuni Shibata; Koji Yoshida; Makoto Kuboki; Shinichiro Yamamoto
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2007-06

10.  Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report.

Authors:  Tsuyoshi Mashitani; Hitoshi Yoshiji; Masaharu Yamazaki; Yasuhide Ikenaka; Ryuichi Noguchi; Masatoshi Ishikawa; Hideto Kawaratani; Norihide Matsuo; Masahito Uemura; Junichi Yamao; Masao Fujimoto; Akira Mitoro; Masahisa Toyohara; Motoyuki Yoshida; Masayoshi Sawai; Chie Morioka; Tatsuhiro Tsujimoto; Mitsuteru Kitade; Kosuke Kaji; Yosuke Aihara; Hiroshi Fukui
Journal:  Cases J       Date:  2009-01-07
View more
  1 in total

1.  Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C.

Authors:  Kazuhide Takata; Fuminori Ishii; Yotaro Uchida; Hiromi Fukuda; Ryo Yamauchi; Kaoru Umeda; Naoaki Tsuchiya; Takashi Tanaka; Keiji Yokoyama; Daisuke Morihara; Yasuaki Takeyama; Satoshi Shakado; Shotaro Sakisaka; Fumihito Hirai
Journal:  Intern Med       Date:  2020-04-30       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.